Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Supernus Pharmaceuticals reported $19.6M in Cost of Sales for its fiscal quarter ending in September of 2023.

Cost Of Sales Change Date
Abbott USD 4.61B 122M Sep/2023
ANI Pharmaceuticals USD 48.1M 5.82M Sep/2023
Aurora Cannabis CAD 52.09M 32.06M Mar/2023
Bristol-Myers Squibb USD 2.49B 350M Sep/2023
Canopy Growth CAD 46.17M 56.62M Sep/2023
Cara Therapeutics USD 1.56M 140K Sep/2023
Corcept Therapeutics USD 1.64M 71K Sep/2023
Eisai JPY 36.43B 7.49B Sep/2023
Eli Lilly USD 1.86B 52.7M Sep/2023
Marinus Pharmaceuticals USD 455K 69K Sep/2023
Pacira USD 39.75M 8.46M Sep/2023
Perrigo USD 712.6M 52.5M Sep/2023
Pfizer USD 9.63B 6.23B Sep/2023
Revance Therapeutics USD 19.41M 1.89M Sep/2023
Supernus Pharmaceuticals USD 19.6M 1.49M Sep/2023
United Therapeutics USD 70.1M 6M Sep/2023
Xeris Pharmaceuticals USD 8.2M 646K Sep/2023